I actually disagree on this one. Look at how many drug headlines about "miracle" recoveries have we seen? Some may prove useful but do we need to inundate doctors with drugs from anecdotal evidence? HGEN had 6 of 6 survive critical through eind I believe and it may yet prove efficacy... however in a real trial their interim participant numbers were upped...clearly not a miracle...but helpful. We see merck having issues with their miracle cure, rlftf with theirs...all big headline news...until it's not.

The jury is still out on cydy and regn to prove efficacy. I'm hopeful, but it's clear that headlines don't save patients. Drugs that prove their efficacy do.

My opinion anyway. Worth what you paid for it.

Now if the FDA saw the interim data and it was phenomenal, but they still wanted to see the trial finish?? Then I'd have a bone to pick with them.